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Abstract
Purpose—To estimate quality-adjusted life expectancy (QALE) loss among US adults due to 
depression and QALE losses associated with the increased risk of suicide attributable to 
depression.
Method—We ascertained depressive symptoms using the eight-item Patient Health Questionnaire 
(PHQ-8) on the 2006, 2008, and 2010 Behavioral Risk Factor Surveillance System (BRFSS) 
surveys. We estimated health-related quality of life (HRQOL) scores from BRFSS data (n = 
276,442) and constructed life tables from US Compressed Mortality Files to calculate QALE by 
depression status. QALE loss due to depression is the difference in QALE between depressed and 
non-depressed adults. QALE loss associated with suicide deaths is the difference between QALE 
from only those deaths that did not have suicide recorded on the death certificate and QALE from 
all deaths including those with a suicide recorded on the death certificate.
Results—At age 18, QALE was 28.0 more years for depressed adults and 56.8 more years for 
non-depressed adults, a 28.9-year QALE loss due to depression. For depressed adults, only 0.41 
years of QALE loss resulted from deaths by suicide, and only 0.26 years of this loss could be 
attributed to depression.
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Conclusion—Depression symptoms lead to a significant burden of disease from both mortality 
and morbidity as assessed by QALE loss. The 28.9-year QALE loss at age 18 associated with 
depression markedly exceeds estimates reported elsewhere for stroke (12.4-year loss), heart 
disease (10.3-year loss), diabetes mellitus (11.1-year loss), hypertension (6.3-year loss), asthma 
(7.0-year loss), smoking (11.0-year loss), and physical inactivity (8.0-year loss).
Keywords
Depression; Suicide; Health-related quality of life (HRQOL); Quality-adjusted life expectancy 
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Introduction
Depression can include several symptoms associated with cognition, negative affect, 
anxiety, and somatization and can present in individuals in various ways including brief 
symptoms that often resolve on their own or frequently recurring symptoms that can lead to 
chronic debilitating mental illness [1]. The prevalence for one kind of chronic depression, 
major depression, is relatively consistent across large nationally representative surveys: 6.7 
% in the past 12 months and 16.6 % over a lifetime [2]. When symptoms that may indicate 
depression occur within the past 2 weeks, the prevalence of major depression ranges from 
3.0 to 3.5 % [3]. When any such symptoms occur within the last 2 weeks, including major 
depression as well as episodic depression, the prevalence of depression ranges from 7 to 9 % 
[3].
Depression is a risk factor for many chronic conditions such as cardiovascular diseases and 
neurological disorders and is associated with risky behaviors such as drug, tobacco, and 
alcohol abuse [4–7]. Depression is also associated with poor health-related quality of life 
(HRQOL) and increases the number of years of life lived with disabilities [8, 9]. Depression 
can be life threatening and has been associated with excess mortality and substantially lower 
life expectancy [10, 11]. In a longitudinal study of elderly individuals followed up to 48 
months, individuals diagnosed with major depression were twice as likely to die as those 
without depression [12]. Although this increased mortality risk may be indirectly caused by 
chronic conditions including diabetes and obesity and risky behaviors such as alcohol and 
drug use, depression alone is likely to be directly responsible through suicide for a 
proportion of its increased mortality risk [13, 14]. Most individuals who commit suicide 
have psychiatric illnesses [15]. In a systematic review of risk factors associated with suicide 
among depressed individuals, many of the most important risk factors included symptoms 
and conditions associated with depression such as more severe depression (OR = 2.20), 
hopelessness (2.20), anxiety (OR = 1.59), and the misuse of alcohol and drugs (OR = 2.17) 
[16]. In one longitudinal study, 8 % of individuals with a major depressive disorder 
attempted suicide over an 18-month period [17]. However, these studies have many 
methodological weaknesses that include less representative samples of older patients in 
clinical settings with multiple chronic conditions, especially those with serious mental 
illness [12, 17]. Estimates are lacking of the long-term health consequences and losses 
among representative samples of individuals with depression compared to individuals 
without depression across their entire life spans as well as comparisons of health losses for 
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those with depression compared to those with other chronic conditions. The magnitude of 
the impact of depression on suicide and the number of years of life lost due to the increased 
risk of suicide among those with depression are also unknown [13, 17].
Much of the lifetime burden of disease of depression is associated with the early age of 
onset of depression. In the National Comorbidity Survey (NCS), the median ages of onset 
for major depression, dysthymia, and bipolar disorders were 32, 31, and 25 years, 
respectively [2, 18], significantly younger than the ages of onset for most other chronic 
conditions such as heart disease and diabetes. Several different methods are available to 
assess the lifetime burden of disease for a condition such as the years lived with a disability 
(YLDs), disability-adjusted life years (DALYs), and quality-adjusted life years (QALYs) 
[19]. In the Global Burden of Disease Study that estimated YLDs worldwide for all 
infectious and chronic disease conditions, depression was the second leading cause of YLDs 
[8, 9]. Furthermore, when major depression is combined with other psychiatric conditions 
that include significant depressive symptoms (e.g., dysthymia and bipolar disorder), this 
combined estimate for depression is the leading health condition worldwide in terms of 
DALYs and YLDs [20].
QALYs and an associated measure, quality-adjusted life expectancy (QALE), take into 
account both the years of life lost and the relative severity of disease, making it possible to 
quantify the total health losses of both non-fatal and fatal mortality outcomes for affected 
patients or a target population [19, 21–23]. The burden of disease for non-fatal outcomes for 
QALYs and QALEs use preference-based HRQOL measures to assess both how a person 
perceives her/his health and how much that person values one health state versus another 
state. Preference-based HRQOL measures capture respondents’ health states using a 
summary score anchored at 0 (dead) and 1 (perfect health) [19]. Thus, 1 year of life lived at 
a health state valued at 0.5 is assessed as 0.5 quality-adjusted life years (QALYs), the same 
as only a half year of life lived in perfect health [21, 22]. QALE at a certain age is defined 
and calculated as the average number of QALYs throughout the remainder of expected life 
[21, 22]. One advantage of QALE over DALY or YLD is that QALE uses the health state 
value to weight life years, so that calculating QALE loss due to depression could be useful 
for evaluating the economic cost of depression and for analyzing the cost-effectiveness of 
treatments and interventions [19, 21–23].
The first aim of this study is to estimate QALE losses due to depression for US adults and to 
compare such losses due to depression with previously reported losses due to five other 
common chronic conditions (stroke, heart disease, diabetes mellitus, hypertension, and 
asthma) and two significantly harmful health behaviors, smoking and physical inactivity. 
The second aim of this study is to estimate QALE loss due to increased risk of suicide death 
attributable to depression. This is the first study we are aware of to estimate QALE losses 
due to depression as well as losses due to increased risk of suicide death attributable to 
depression.
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Materials and methods
We calculated QALE loss due to depression in four steps. First, using data from the 
Behavioral Risk Factor Surveillance System (BRFSS), we calculated HRQOL values as a 
function of age and depression outcome. Second, we estimated age-specific mortality rates 
stratified by depression status using the Compressed Mortality File. Third, using the 
estimated age-specific mortality rates from step 2, we constructed life tables to calculate life 
expectancy as a function of depression and estimate years of life lost due to depression. 
Fourth, we calculated QALE by combining estimated HRQOL values from step 1 and life 
tables from step 3. We calculated QALE by depression outcome and estimated QALE loss 
due to depression.
Sample
The Behavioral Risk Factor Surveillance System (BRFSS), a state-based annual health 
survey of non-institutionalized civilian US residents, uses random-digit-dialed telephone 
survey methods to ascertain sociodemographic characteristics, behavioral risk factors, and 
health outcomes in a population-based random sample of adults 18 years or older [24–26].
BRFSS has included the eight-item Patient Health Questionnaire (PHQ-8) depression scale 
as an optional module to estimate depressive symptoms and depression status during 2006, 
2008, and 2010 [27]. The PHQ-8 is a valid diagnostic and severity measure for depressive 
disorders in large clinical studies [28] and for estimating depression prevalence [3, 27, 29]. 
Thirty-six States and the District of Columbia administered the PHQ-8 at least once during 
these three survey years, yielding a total sample size of 276,442. Current depression in this 
study is defined as PHQ-8 index ≥10 [27]. The PHQ-8 score of ≥10 has 88 % sensitivity and 
88 % specificity for major depression and represents clinically significant depressive 
symptoms [4, 28, 30].
The BRFSS includes information on respondent sociodemographic characteristics, risky 
behaviors, and certain diseases related to current depression. We included these variables in 
analyses of the depression outcome to assess potential associations with these variables. The 
sociodemographic characteristics analyzed in this study included age, sex, race/ethnicity, 
marital status, and educational achievement. The risky behaviors included were weight 
differences from normal weight based on the body mass index (BMI)—underweight (BMI < 
18.5 kg/m2), overweight (25 ≤ BMI <30 kg/m2), and obese (BMI ≥ 30.0 kg/m2); current 
cigarette smoking (respondents who report both having smoked at least 100 cigarettes in 
their lifetimes and currently smoke); physical inactivity (respondents who report doing no 
physical activity or exercise during the past 30 days other than that for their regular job); and 
heavy alcohol drinking (men who report having three or more alcoholic drinks per day and 
women who report having two or more alcoholic drinks per day). We also assessed 
associations with cardiovascular-related diseases [had either a heart attack (myocardial 
infarction), angina or coronary heart disease, or a stroke].
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Non-fatal health loss due to depression
Non-fatal health loss due to depression was defined and calculated as the decrease in 
HRQOL scores for those with current depression compared to those without current 
depression. The BRFSS questionnaire includes a set of four HRQOL questions that asks 
respondents to report their general health status (excellent, very good, good, fair, or poor) 
and the numbers of physically unhealthy days, mentally unhealthy days, and days with 
activity limitation during the past 30 days [31]. We applied a published mapping algorithm 
to obtain values of EuroQol Group’s EQ-5D index, a preference-based HRQOL 
measurement, from the four BRFSS HRQOL items [32, 33]. This algorithm provides valid 
estimates of EQ-5D scores with a relative bias of less than 1 % of the actual observed 
EQ-5D [33].
We calculated mean EQ-5D, standardized to the year 2010 US population, for those with 
current depression and those without current depression, and then estimated the difference in 
age-adjusted EQ-5D between those with current depression and those without current 
depression as the non-fatal health loss due to depression.
Fatal health loss due to depression
Fatal health loss due to depression was defined as years of life lost due to depression and 
was operationalized as the difference in life expectancy between those with current 
depression and those without current depression [34]. Life expectancy at a given age is the 
expected/average number of years of life remaining starting at that age and is calculated 
from age-specific mortality rates [35, 36]. The National Center for Health Statistics 
compiles death data for the US population from death certificates and makes these data 
available to the public in the Compressed Mortality File at http://wonder.cdc.gov. The US 
Census Bureau provides annual population estimates (accessible at www.census.gov/popest/
states/asrh/). Both sets of data include age, gender, and other basic demographics, and can 
be used to estimate age-specific mortality rates for the US population overall, by sex, and by 
some race/ethnicity subgroups.
Because age-specific mortality rates stratified by depression status are not available, these 
rates were estimated from three variables—age-specific mortality rates of total population, 
the proportion of the population with depression, and the hazard ratio of death for those with 
depression relative to those without depression [37]. We estimated the proportion of the 
population with depression from the BRFSS and the hazard ratios from the 1999–2004 
National Health and Nutrition Examination Survey (NHANES) data as linked to the 
National Death Index through December 31, 2006 (http://www.cdc.gov/nchs/data_access/
data_linkage/mortality/nhanes_99_04_ linkage.htm).
QALE loss due to depression
Like life expectancy, quality-adjusted life expectancy (QALE) at a certain age is the 
expected/average number of quality-adjusted life years (QALYs) remaining starting at that 
age and is calculated from age-specific mortality rates and corresponding average HRQOL 
scores [23, 36]. We constructed life tables to calculate life expectancy and QALE using the 
age-specific mortality rates and EQ-5D scores. For each year age interval (18–24, 25–34,…, 
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85 +), we obtained the mortality rates (per year per person) by dividing the numbers of 
deaths in that age interval by the number of persons in that age interval in the population. 
We assumed a constant probability of death during each age interval and could thus obtain 
estimated years of life within the interval [35, 36]. We calculated the QALYs during each 
age interval by multiplying the life-years within an interval by the corresponding mean 
EQ-5D value. Life expectancy and QALE for those at a certain age (such as 18 years old) 
are the average life years and QALYs starting from this age to the last age interval, 
respectively.
We used the estimated age-specific mortality rates and EQ-5D scores, stratified by 
depression status, to construct depression-specific life tables and to calculate QALE by 
respondents’ depression status. Similar to years of life lost due to depression, QALE loss 
due to depression was defined and estimated as the difference in QALE between those with 
current depression and those without current depression [37, 38].
QALE loss due to increased risk of suicide death
Suicide deaths are a subset of deaths from all causes. Suicide-associated QALE loss is 
defined as the impact on QALE due to additional deaths through suicide. This does not 
include losses due to non-fatal suicide attempts. We calculated this loss as the difference 
between the QALE from using only those deaths that did not have suicide recorded on the 
death certificate and the QALE from using all deaths including those with a suicide 
recorded. Because the risk of suicide is higher among those with depression than among 
those without depression, we estimated the additional QALE loss due to this increased risk 
of suicide death attributable to depression as the difference in the suicide-associated QALE 
loss between those with and those without depression.
Ethics
This analysis used de-identified data produced by federal agencies in the public domain. 
Data were downloaded from the Centers for Disease Control and Prevention website (ftp://
cdc.gov/pub).
Results
We first report our descriptive results (Table 1). Approximately, 9.1 % of US adults were 
currently depressed based on responses to the PHQ-8. The prevalence of current depression 
was higher among adults 18–64 years old than older adults. After age adjustment, the 
prevalence of depression was statistically associated with sex, race/ethnicity, marital status, 
and education. Specifically, the prevalence of depression was higher among women than 
men; black non-Hispanics than other race/ethnicity groups; divorced, separated, or never 
married adults than married, widowed, or unmarried cohabiting adults; and adults with less 
education than those with more education. Current depression was also more common 
among those who were underweight or obese, current cigarette smokers, physically inactive, 
and heavy alcohol drinkers. Those who had cardiovascular diseases were more than twice 
(20.1 %) as likely to be currently depressed as those who did not have cardiovascular 
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disease (8.0 %). Nearly half (45.6 %) of adults who reported “poor” general health and 22.1 
% of adults who reported “fair” general health were currently depressed.
We also observed gender differences in the magnitude of associations between some of 
these predictors and current depression. For example, compared to women with depression, 
men with depression were more likely to have cardiovascular diseases (age-adjusted OR = 
1.6), to be heavy drinkers (OR = 2.1), to be current smokers (OR = 1.3), and to be divorced, 
separated, or never married (OR = 1.2).
We now report our analytic results (Tables 2, 3, 4). For those with depression, the age-
adjusted EQ-5D index was 0.598, 0.307 points (34 %) lower than those without depression 
(0.905) (Table 2). Across subgroups defined by age, sex, race/ethnicity, and simultaneously 
by race and sex, those who were depressed had consistently lower EQ-5D scores than those 
who were not depressed. This adverse impact of depression on the EQ-5D index was 
significantly larger for those 65 years old or older (0.509 points lower) than those 18–44 
years old (0.213 points lower) or those 45–64 years old (0.413 points lower); larger for men 
(0.327 points lower) than women (0.304 points lower); and larger for white non-Hispanics 
(0.337 points lower) than black non-Hispanics (0.266 points lower) and Hispanics (0.229 
points lower).
The life expectancy at age 18 years was 47.3 more years for those with depression and 63.7 
more years for those without depression. This 16.4-year (26 %) decrease represents the years 
of life lost due to depression, starting at age 18. The loss in life expectancy at age 18 for men 
with depression was 18.2 years, significantly more than the 15.3 years of life lost for women 
with depression (p < 0.0001). Although the decreases in EQ-5D index were larger for white 
non-Hispanics than for other groups, the losses in life expectancy due to depression were 
significantly less for white non-Hispanics (16.1 years) than for black non-Hispanics (18.5 
years) and for Hispanics (18.0 years).
The lower EQ-5D and life expectancy among those with depression yield a significantly 
lower QALE among those with depression (Table 3). The QALE for an 18-year-old with 
depression, for example, was 28.0 years, 28.9 years less than that of an 18-year-old without 
depression (56.8 years). This represents a decrease of QALE by more than half (51 %) for 
those with depression. Although QALE declined with age, depression-associated QALE 
losses were significant at all ages. For example, an 85-year-old person with depression had a 
significantly lower QALE (0.9 year) than an 85-year-old person without depression (6.9 
years), a 6.0-year loss in QALE. The depression-associated QALE loss at age 18 was 
significantly larger among men (29.6-year loss) than among women (28.6-year loss) and 
larger among white non-Hispanics (29.3-year loss) than among black non-Hispanics (26.8 
years) and among Hispanics (26.4-year loss), though this difference between white non-
Hispanics and Hispanics was not statistically significant (p = 0.1).
The second aim of this study estimated suicide-associated QALE loss (Table 4). For those 
with depression, the calculated QALE at age 18 using non-suicide mortality rates was 28.38 
years, 0.41 years more than that using mortality rates including suicides (27.97 years). Thus, 
death by suicide contributed 0.41 years of QALE loss for those with depression. Similarly, 
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death by suicide contributed only 0.15 years of QALE loss for those without depression. 
This 0.26-year difference (0.26 = 0.41–0.15) was the additional QALE loss associated with 
the increased risk for suicide among those with depression. Men lost more QALE to suicide 
death than women did, both for those with depression and those without depression. The 
additional QALE loss for men with depression due to their increased risk of death through 
suicide was 0.55 years, more than threefold that of the 0.14-year additional loss for women 
with depression.
Finally, we conducted a sensitivity analysis to examine the impact of suicide 
misclassification within death certificates on the QALE loss due to suicide. We included all 
unknown accident deaths as suicide deaths (i.e., new suicides = recorded suicides + 
unknown accident deaths) and recalculated the QALE loss due to suicide. The new 
calculated value of the additional QALE loss associated with the increased risk for suicide 
among depressed adults increased from 0.26 years to 0.29 years of QALE loss.
Discussion
These analyses confirmed previous studies suggesting large adverse impacts of depression 
on both fatal and non-fatal outcomes [4, 13, 39]. The estimated burden of disease for 
depression for depressed individuals during their entire life span starting at age 18 was 28.9 
years of QALE loss, a loss of more than half their QALE at this age. This result is consistent 
with previous studies that have shown a dramatic decrease in life expectancy for those with 
serious mental illnesses [40, 41]. This 28.9-year loss in QALE also markedly exceeds that of 
other chronic conditions such as stroke (12.4-year loss), heart disease (10.3-year loss), 
diabetes mellitus (11.1-year loss), hypertension (6.3-year loss), and asthma (7.0-year loss), 
and the risk factors such as smoking (11.0-year loss) and physical inactivity (8.0-year loss) 
reported previously (Fig. 1) [22, 37, 42]. This QALE loss also mirrors other studies 
concluding that depression is the top health condition worldwide in terms of disability-
adjusted life years (DALYs) [20]. At least three reasons may explain this excessive QALE 
loss. First, the non-fatal health losses due to depression appear significantly larger than the 
loss due to each of the other chronic conditions mentioned previously. Major depressive 
disorder contributed 917 years lived with a disability (YLDs) per 100,000 persons annually, 
more than those of these five other chronic conditions mentioned above combined (821 
YLDs per 100,000) [9]. In our study, depression decreased the EQ-5D index by 0.307 
points, equivalent to a decrease in the EQ-5D index from having no chronic conditions to 
having between five and six chronic conditions [43] and significantly more than the 0.07–
0.16 point decrease associated with any of the five other conditions and the two risky 
behaviors [22, 37, 42]. Second, depression affected mortality and life expectancy more than 
the other conditions. People with serious mental illness, which includes clinical depression, 
died an average of 25 years sooner than those in the general population [44]. In this study, 
depression decreased life expectancy at age 18 by 16.4 years, significantly more than that of 
the other five chronic conditions [22] and two risky behaviors [37, 42], which ranged from 
3.1 years (hypertension) to 9.8 years (stroke). Third, much of the lifetime burden of disease 
associated with depression is based on its early age of onset. The median ages of onset for 
major depression (32 years), dysthymia (31 years), and bipolar disorders (25 years) are 
significantly younger than those for most other chronic conditions such as heart disease and 
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diabetes mellitus [2]. For example, about 75 % of heart disease and 84 % of stroke occur 
first after age 55 [22]. In this study, the depression prevalence was significantly higher 
among younger persons (9.8 % for those < 65 years) than older persons (5.3 % for those ≥65 
years).
Although age-adjusted depression prevalence rates in women exceeded those in men, the 
QALE losses associated with depression were one year more in men than in women. This 
difference in QALE losses between men and women resulted from the difference in the 
impacts on both fatal and nonfatal outcomes. Men lost significantly more years of life and 
experienced larger EQ-5D losses to depression than women. Compared to women with 
depression, men with depression were more likely to have cardiovascular diseases, to be 
heavy drinkers, to be current smokers, and to be divorced, separated, or never married. All 
of these factors are associated with poor health outcomes. Depression also has a much large 
impact on mortality among men than women [13, 45, 46]. Among three race/ ethnicity 
subgroups in our study, depression decreased the EQ-5D index more but decreased life 
expectancy less in white non-Hispanics than in black non-Hispanics and Hispanics, though 
the combined QALE loss among white non-Hispanics (28.6-year loss) significantly 
exceeded that among black non-Hispanics (25.8-year loss).
Our descriptive analyses of depression confirmed previous studies of associations between 
depression and some sociodemographic characteristics, risky behaviors, and diseases [4–7, 
13, 39]. Although these variables are potential confounders for the decreased QALE among 
depressed individuals, our QALE estimates were not adjusted for these factors. Therefore, 
the term “QALE loss due to depression” does not suggest a causal relationship. However, 
our estimated QALE loss due to depression markedly exceeds that of diseases associated 
with depression, such as heart diseases and stroke, and risky behaviors, such as smoking and 
physical inactivity [22, 37, 42]. In addition, our study used similar methods to these previous 
studies and is consistent with currently accepted methods in the literature. These findings 
strongly suggest that depression contributes lower QALE among individuals with depression 
independent of these diseases and risk factors.
Depression may be directly related to the increased risk of death through suicide [13, 14] 
because a large proportion of persons who committed suicide had pre-existing depression [1, 
47]. Nonetheless, in this study, suicide contributed very little to QALE loss for both those 
with depression (0.41 years) and those without depression (0.15 years). Only 0.26 years of 
additional QALE losses for those with depression could be attributed to their increased risk 
of suicide. This 0.26 years of QALE loss was much smaller than the nearly 30 years of 
overall QALE loss due to depression: Only 0.9 % (1.8 % for men and 0.5 % of for women) 
of the depression-associated QALE loss was due to the increased risk of suicide among 
those with depression. This most likely results from the fact that, although many who die 
from suicide suffer from mental disorders [48], almost all of those individuals diagnosed 
with a mental disorder including those with clinical depression do not die directly from 
suicide but from other causes [3, 13, 49]. Only 1.4 % (2.3 % for men and 0.58 % for 
women) of all deaths among US adults had an underlying cause of suicide, even though 
suicide is the second leading cause of death among those aged 15–24 years [1, 50]. Related 
to this, depression usually is associated with inactivity, lethargy, and a general decline in 
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health practices and self-care which puts those with depression at higher risk for other 
chronic conditions [47]. Because the Compressed Mortality File, compiled from death 
certificates, might underreport suicides and misclassify some suicide deaths as unknown 
deaths from injuries [51, 52], this study may have underestimated the impact of suicide on 
QALE loss. However, our sensitivity analysis showed that even attributing all unknown 
deaths from injuries as suicide deaths increased the estimated additional QALE loss 
associated with the increased risk for suicide among those with depression only 0.03 years, 
from 0.26 years to 0.29 years.
This study has several weaknesses. First, the PHQ-8 is not a clinical diagnostic tool for 
diagnosing depression but has been used primarily as a screening instrument for estimating 
the prevalence of depression in the general population. This would tend to reduce the 
accuracy and the reliability of the population estimates relative to a clinical diagnosis or 
interview. Second, the reporting of depressive symptoms might show mode effects that may 
have affected our estimates; individuals administered face-to-face interviews tend to report 
better health (social desirability effects) than those interviewed by telephone [3, 53]. The 
estimated prevalence of current depression using the BRFSS, a telephone survey, was higher 
(9.1 %) than the estimates using the NHANES, an in-person interview (6.8 %) [3]. However, 
such a higher estimated prevalence for depression would have resulted in a relatively small 
change in the estimated depression-associated QALE loss. For example, if we had used the 
estimated depression prevalence from the NHANES (6.8 % overall), the estimated QALE 
loss due to depression would be 28.6 years, only 0.23 year less than the 28.9 years of the 
estimated QALE loss based on the estimated 9.1 % overall depression prevalence from the 
BRFSS. Third, the BRFSS data are collected via telephone interviews using a random-digit-
dialed methodology that most likely underestimates the prevalence of depression because 
the study population includes only non-institutionalized household members. However, our 
analysis demonstrates that underestimating depression prevalence would have a small effect 
on the estimation of QALE loss due to depression. Fourth, our estimated hazard ratios from 
the NHANES linked mortality data exceed others reported in the literature [12, 45], and 
using larger estimates of these hazard ratios would overestimate depression-associated 
QALE losses. If we had used the smaller estimated hazard ratio by Sullivan et al. [12] and 
Zheng et al. [45], the estimated QALE losses would be 26.2 years (28.1 years for men and 
25.0 years for women). However, such estimates were not statistically significantly different 
from the estimated QALE losses in this study. Fifth, this study relies on the BRFSS’s 
unhealthy days questions to estimate preference-based HRQOL scores indirectly rather than 
on direct measurements of these scores. Therefore, our estimates of QALE loss are likely to 
be smaller than the true values due to “regression to the mean” [32–37]. One study estimated 
the bias of estimated QALE loss using the estimated EQ-5D scores and found that this bias 
was less than 2.5 % of that using the actual EQ-5D questions [36]. Finally, not all the US 
states used the PHQ-8 questionnaire. Thus, if the prevalence of depression in the states using 
this questionnaire differed from that in the states not using this questionnaire, these results 
may not be fully generalizable to the entire US population. However, our analysis above on 
the small effects of differences in estimated depression prevalence on QALE loss due to 
depression may mitigate this lack of generalizability.
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This study is the first we know of to estimate burden of disease for depression by comparing 
the QALE for currently depressed persons to that for non-depressed persons. QALE is a 
single index that encompasses both depression-related fatal and nonfatal outcomes. 
Therefore, our results are particularly useful in directly comparing the burdens of disease for 
depression to the burdens of disease for other chronic conditions and risky behaviors and for 
estimating the economic costs of depression among U.S adults [19–23]. The overall burden 
of depression was at least twice as large as the burdens of some common chronic conditions 
such as stroke, heart disease, diabetes mellitus, hypertension, and asthma and of the risk 
factor of smoking. This information could be useful to local and state authorities when 
setting health priorities and when dealing with mental problems in the general adult 
population [54, 55]. These results will also likely to motivate the development of improved 
prevention efforts and strategies for individuals at risk for depression and suicide [56–58].
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Fig. 1. 
Comparison of quality-adjusted life expectancy (QALE) losses due to depression, diabetes 
mellitus [22], hypertension [22], asthma [22], heart disease [22], stroke [22], smoking [37], 
and physical inactivity [42]
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Table 1
Proportions of Current Depression among US adults by various characteristics
Characteristics Proportion of current
depression
N Percentagea SE (%)
All 276,442 9.1 0.13
Age
  18–44 85,974 9.6 0.21
  45–64 116,716 10.0 0.20
  65+ 73,752 5.3 0.17
Sex
  Men 105,354 7.1 0.44
  Women 171,080 11.0 0.44
Race/ethnicity
  White non-Hispanics 217,215 8.6 0.43
  Black non-Hispanics 26,234 11.8 0.54
  Hispanics 14,505 9.4 0.65
  Others 16,526 8.7 0.65
Marital status
  Married/widowed/unmarried couples 196,679 7.2 0.44
  Divorced/separated/never married 79,057 13.5 0.46
Education
  <High School 25,306 17.2 0.73
  High school/some college 158,346 10.1 0.44
  College graduate 92,485 4.6 0.41
Body mass index (BMI) category, (kg/m2)
  <18.5 (underweight) 4,476 13.4 1.23
  18.5 to <25 (normal weight) 93,014 7.4 0.45
  25 to <30 (overweight) 96,844 7.6 0.45
  ≥30 (obese) 72,421 13.2 0.48
Current smoking
  Yes 50,206 17.9 0.54
  No 225,337 6.9 0.41
Physical activity
  Yes 207,032 6.6 0.41
  No 69,215 17.1 0.56
Heavy alcohol drinking
  Yes 13,443 12.6 0.85
  No 258,662 8.9 0.42
Cardiovascular diseases
  Yes 30,246 20.1 0.75
  No 244,031 8.0 0.43
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Characteristics Proportion of current
depression
N Percentagea SE (%)
Self-rated general health
  Excellent 52,535 2.2 0.43
  Very Good 90,222 4.1 0.42
  Good 83,350 9.5 0.53
  Fair 34,696 22.1 0.72
  Poor 14,869 45.6 1.06
SE standard error of estimate
aWeighted proportions of depression, for subgroups except age group itself, proportions were adjusted by age
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